{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:23:48Z","timestamp":1786994628300,"version":"build-2736575974"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007379","name":"Fondation pour l'Aide \u00e0 la Recherche sur la Scl\u00e9rose en Plaques","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nbd.2020.104869","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T20:41:16Z","timestamp":1586464876000},"page":"104869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis"],"prefix":"10.1016","volume":"140","author":[{"given":"Carolina","family":"Melero-Jerez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana","family":"Alonso-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mo\u00f1ivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Lebr\u00f3n-Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Mach\u00edn-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7018-8032","authenticated-orcid":false,"given":"Fernando","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4829-9497","authenticated-orcid":false,"given":"Diego","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.104869_bb0005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn.2887","article-title":"Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool","volume":"14","author":"Ajami","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2020.104869_bb0010","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.4049\/jimmunol.1202556","article-title":"Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells","volume":"191","author":"Alabanza","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2014.02.003","article-title":"New regulatory CD19(+)CD25(+) B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids","volume":"270","author":"de Andres","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jneuroim.2014.11.006","article-title":"Absence of the memory response to encephalitogen following intergender adoptively transferred experimental autoimmune encephalomyelitis","volume":"278","author":"Archie Bouwer","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1172\/JCI0215751","article-title":"Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12","volume":"110","author":"Becher","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2020.104869_bb0030","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104869_bb0035","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.24620","article-title":"Dynamic imaging of individual Remyelination profiles in multiple sclerosis","volume":"79","author":"Bodini","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0040","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s13311-017-0577-0","article-title":"Remyelinating pharmacotherapies in multiple sclerosis","volume":"14","author":"Bove","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2020.104869_bb0045","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/awq250","article-title":"Demyelination versus remyelination in progressive multiple sclerosis","volume":"133","author":"Bramow","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104869_bb0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuroimage.2006.03.028","article-title":"Early macrophage MRI of inflammatory lesions predicts lesion severity and disease development in relapsing EAE","volume":"32","author":"Brochet","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2020.104869_bb0055","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2020.104869_bb0060","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awp289","article-title":"Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis","volume":"132","author":"Brucklacher-Waldert","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104869_bb0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-016-1621-6","article-title":"Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"133","author":"Cantoni","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104869_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bpa.12762","article-title":"Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein","volume":"30","author":"Castoldi","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2020.104869_bb0075","series-title":"Emerging Drugs and Targets in Multiple Sclerosis","first-page":"222","article-title":"Regulation of oligodendrocyte differentiation: new targets for drug discovery in remyelination","author":"de Castro","year":"2019"},{"key":"10.1016\/j.nbd.2020.104869_bb0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2012.11.003","article-title":"Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE","volume":"42","author":"Christy","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.nbd.2020.104869_bb0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/19490976.2017.1353843","article-title":"A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis","volume":"8","author":"Colpitts","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.nbd.2020.104869_bb0090","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10875-008-9236-x","article-title":"Multiple sclerosis and regulatory T cells","volume":"28","author":"Costantino","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0095","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1128\/JVI.75.13.6115-6120.2001","article-title":"Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus","volume":"75","author":"Dandekar","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2020.104869_bb0100","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1172\/JCI92387","article-title":"Neural precursor cell-secreted TGF-beta2 redirects inflammatory monocyte-derived cells in CNS autoimmunity","volume":"127","author":"De Feo","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2020.104869_bb0105","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awl074","article-title":"The contribution of demyelination to axonal loss in multiple sclerosis","volume":"129","author":"DeLuca","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104869_bb0110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1517\/14712590902762781","article-title":"Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b","volume":"9","author":"Durelli","year":"2009","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.nbd.2020.104869_bb0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta","volume":"65","author":"Durelli","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/brain\/awx008","article-title":"Adaptive human immunity drives remyelination in a mouse model of demyelination","volume":"140","author":"El Behi","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104869_bb0125","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1084\/jem.192.6.899","article-title":"CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis","volume":"192","author":"Fife","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2020.104869_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.nbd.2020.104869_bb0135","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1073\/pnas.1619424114","article-title":"Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin","volume":"114","author":"Fournier","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104869_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/ana.25128","article-title":"Myeloid cell plasticity in the evolution of central nervous system autoimmunity","volume":"83","author":"Giles","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/imcb.1025","article-title":"Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis","volume":"96","author":"Gjelstrup","year":"2018","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.nbd.2020.104869_bb0150","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104869_bb0155","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s12325-016-0474-7","article-title":"Modulation of Neuroinflammation in the central nervous system: role of chemokines and sphingolipids","volume":"34","author":"Gualtierotti","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.nbd.2020.104869_bb0160","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0165","article-title":"Blood B cell and regulatory subset content in multiple sclerosis patients","volume":"2","author":"Habib","year":"2015","journal-title":"J. Mult. Scler. (Foster City)"},{"key":"10.1016\/j.nbd.2020.104869_bb0170","first-page":"277","article-title":"Multiple sclerosis - remyelination failure as a cause of disease progression","volume":"27","author":"Hagemeier","year":"2012","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.nbd.2020.104869_bb0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.0903573","article-title":"CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice","volume":"185","author":"Haile","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0180","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/msj.20246","article-title":"Axonal damage in multiple sclerosis","volume":"78","author":"Haines","year":"2011","journal-title":"Mt Sinai J. Med."},{"key":"10.1016\/j.nbd.2020.104869_bb0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneumeth.2017.04.003","article-title":"Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL\/6 mice for the longitudinal study of pathology and repair","volume":"284","author":"Hasselmann","year":"2017","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2020.104869_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cellimm.2005.11.002","article-title":"Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis","volume":"237","author":"Hofstetter","year":"2005","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0195","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.172.4.1025","article-title":"Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages","volume":"172","author":"Huitinga","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2020.104869_bb0200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/eji.1830230321","article-title":"Treatment with anti-CR3 antibodies ED7 and ED8 suppresses experimental allergic encephalomyelitis in Lewis rats","volume":"23","author":"Huitinga","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0205","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/sctm.17-0028","article-title":"Dynamic changes in brain mesenchymal perivascular cells associate with multiple sclerosis disease duration, active inflammation, and demyelination","volume":"6","author":"Iacobaeus","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.nbd.2020.104869_bb0210","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-017-1745-3","article-title":"Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology","volume":"134","author":"Ineichen","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104869_bb0215","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"International Multiple Sclerosis Genetics","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104869_bb0220","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4049\/jimmunol.1101816","article-title":"Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease","volume":"188","author":"Ioannou","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/iji.12388","article-title":"TNFRSF1A polymorphisms and their role in multiple sclerosis susceptibility and severity in the Slovak population","author":"Javor","year":"2018","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.nbd.2020.104869_bb0230","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1093\/brain\/awx185","article-title":"Towards personalized therapy for multiple sclerosis: prediction of individual treatment response","volume":"140","author":"Kalincik","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104869_bb0235","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4049\/jimmunol.1900914","article-title":"Cytokines and chemokines in the pathogenesis of experimental autoimmune encephalomyelitis","volume":"204","author":"Karpus","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12967-016-0860-6","article-title":"Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis","volume":"14","author":"Kleist","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.nbd.2020.104869_bb0245","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41590-018-0237-5","article-title":"Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity","volume":"19","author":"Knier","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0250","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0255","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fneur.2016.00131","article-title":"Development of a sensitive outcome for economical drug screening for progressive multiple sclerosis treatment","volume":"7","author":"Kosa","year":"2016","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2006.05.006","article-title":"Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters","volume":"177","author":"Laplaud","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0265","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000566","article-title":"Different MRI patterns in MS worsening after stopping fingolimod","volume":"6","author":"Lapucci","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.nbd.2020.104869_bb0270","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104869_bb0275","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.4049\/jimmunol.1101578","article-title":"Estrogen receptor alpha signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis","volume":"187","author":"Lelu","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0280","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1177\/1352458517690618","article-title":"Age related multiple sclerosis severity score: disability ranked by age","volume":"23","author":"Manouchehrinia","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.nbd.2020.104869_bb0285","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/eji.201646485","article-title":"Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis","volume":"46","author":"Martin","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0290","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.4049\/jimmunol.179.12.8146","article-title":"Pregnancy suppresses experimental autoimmune encephalomyelitis through immunoregulatory cytokine production","volume":"179","author":"McClain","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0295","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/glia.23317","article-title":"2-AG limits Theiler\u2019s virus induced acute neuroinflammation by modulating microglia and promoting MDSCs","volume":"66","author":"Mecha","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2020.104869_bb0300","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2020.104869_bb0305","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbadis.2015.10.015","article-title":"Myeloid derived suppressor cells in inflammatory conditions of the central nervous system","volume":"1862","author":"Melero-Jerez","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2020.104869_bb0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2019.02.014","article-title":"The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-beta treatment in a murine model of multiple sclerosis","volume":"127","author":"Melero-Jerez","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104869_bb0315","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/WCO.0000000000000454","article-title":"Endothelial cells and lymphatics at the interface between the immune and central nervous systems: implications for multiple sclerosis","volume":"30","author":"Meyer","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0320","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clim.2014.09.011","article-title":"Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis","volume":"155","author":"Michel","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0325","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1093\/brain\/awp144","article-title":"CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system","volume":"132","author":"Mildner","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104869_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1501s77","article-title":"Experimental autoimmune encephalomyelitis in the mouse","author":"Miller","year":"2007","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0335","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1750-3639.2011.00495.x","article-title":"Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis","volume":"21","author":"Moline-Velazquez","year":"2011","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2020.104869_bb0340","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nbd.2014.03.017","article-title":"The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability","volume":"67","author":"Moline-Velazquez","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2020.104869_bb0345","first-page":"357","article-title":"Myeloid cell distribution and activity in multiple sclerosis","volume":"31","author":"Moline-Velazquez","year":"2016","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.nbd.2020.104869_bb0350","first-page":"357","article-title":"Myeloid cell distribution and activity in multiple sclerosis","volume":"31","author":"Molin\u00e9-Vel\u00e1zquez","year":"2016","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.nbd.2020.104869_bb0355","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2008.08.030","article-title":"Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells","volume":"130","author":"Montes","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2007.11.003","article-title":"Role of natural killer cells in the pathogenesis and progression of multiple sclerosis","volume":"57","author":"Morandi","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2020.104869_bb0365","first-page":"114","article-title":"Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis","volume":"54","author":"Moreno","year":"2012","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0370","doi-asserted-by":"crossref","first-page":"13299","DOI":"10.1038\/s41598-019-49868-6","article-title":"CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"9","author":"Morkholt","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2020.104869_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2004.04.006","article-title":"Decreased CD14+CCR2+ monocytes in active multiple sclerosis","volume":"363","author":"Nakajima","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2020.104869_bb0380","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1352458515593821","article-title":"Flow cytometric analysis of T cell\/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression","volume":"22","author":"Nemecek","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.nbd.2020.104869_bb0385","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/brain\/124.1.154","article-title":"Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype","volume":"124","author":"Nijeholt","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2020.104869_bb0390","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1196\/annals.1386.021","article-title":"A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"1089","author":"Offner","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2020.104869_bb0395","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/glia.23148","article-title":"Demyelination induced by oxidative stress is regulated by sphingosine 1-phosphate receptors","volume":"65","author":"O\u2019Sullivan","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2020.104869_bb0400","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2990.2007.00805.x","article-title":"Remyelination can be extensive in multiple sclerosis despite a long disease course","volume":"33","author":"Patani","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.nbd.2020.104869_bb0405","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies: a new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2020.104869_bb0410","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2005.04.027","article-title":"HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype","volume":"167","author":"Prat","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0415","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrneurol.2015.106","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process","volume":"11","author":"Rovira","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0420","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple sclerosis severity score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104869_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040124","article-title":"TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis","volume":"4","author":"Takahashi","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.nbd.2020.104869_bb0430","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0435","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2020.104869_bb0440","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2014.03.009","article-title":"Defining a new biomarker for the autoimmune component of multiple sclerosis: Th40 cells","volume":"270","author":"Waid","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0445","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1212\/01.wnl.0000237551.26858.39","article-title":"Neocortical neuronal, synaptic, and glial loss in multiple sclerosis","volume":"67","author":"Wegner","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2020.104869_bb0450","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3389\/fneur.2017.00598","article-title":"New multiple sclerosis disease severity scale predicts future accumulation of disability","volume":"8","author":"Weideman","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2020.104869_bb0455","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fimmu.2017.00336","article-title":"Adaptive immunity is the key to the understanding of autoimmune and paraneoplastic inflammatory central nervous system disorders","volume":"8","author":"Weissert","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0460","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates TH17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104869_bb0465","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.4049\/jimmunol.0804247","article-title":"Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression","volume":"182","author":"Wu","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0470","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1084\/jem.20132477","article-title":"Differential roles of microglia and monocytes in the inflamed central nervous system","volume":"211","author":"Yamasaki","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2020.104869_bb0475","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.4049\/jimmunol.179.8.5228","article-title":"CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis","volume":"179","author":"Zhu","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2020.104869_bb0480","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.4049\/jimmunol.1100403","article-title":"Plasticity of Ly-6C(hi) myeloid cells in T cell regulation","volume":"187","author":"Zhu","year":"2011","journal-title":"J. Immunol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120301443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120301443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:21:05Z","timestamp":1760851265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120301443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":96,"alternative-id":["S0969996120301443"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104869","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104869"}}